Moreover, NDV-D90 appeared to reduce gastric tumor vascularization, possibly through suppression of vascular endothelial growth factor A (VEGF-A) and Matrix Metallopeptidase 2 (MMP-2). This evidence concerns the gene MMP2 and gastric neoplasm.